NBCD A/S: Financial statements 2023
CVR: 30582462
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
NBCD A/S (CVR 30582462) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 133,708,596 and a net result of DKK 70,806,144 compared with DKK 45,856,530 the year before. That is an increase of 41.2% compared with the year before. Equity in the 2023 report amounted to DKK 194,301,003. The solvency ratio was 64.2%. The company had 31 employees in the financial year.
- Gross Profit
- DKK 133,708,596
- Profit/Loss
- DKK 70,806,144
- Equity
- DKK 194,301,003
- Total Assets
- DKK 302,512,849
- Employees
- 31
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 133.7 mio. | 70.8 mio. | 194.3 mio. | 31 |
| 2022 | - | 94.7 mio. | 45.9 mio. | 123.5 mio. | 23 |
| 2021 | - | 60.4 mio. | 35.6 mio. | 107.6 mio. | 20 |
| 2020 | - | 59.7 mio. | 40.5 mio. | 72 mio. | 23 |
| 2019 | - | 48.9 mio. | 33.7 mio. | 36.5 mio. | 20 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
NBCD A/S has published its annual report for 2022. Gross profit came to DKK 94,669,194, and the net result was DKK 45,856,530.
About NBCD A/S
NBCD A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2007. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named NORDIC BIOSCIENCE CLINICAL DEVELOPMENT A/S and NORDIC BIOSCIENCE PROJECT 2 A/S. The management consists of Jeppe Ragnar Andersen and Mark Høgh Gandrup. The board consists of Pierre Khaitrine (chair), Jeppe Ragnar Andersen and José Ignacio Pfeifer. The company is owned by Sanos Holding A/S. The company has 24 employees (2018). In 2025, the company reported a gross profit of DKK 31,583,144 and a net result of DKK 9,222,892 compared with DKK 52,621,101 the year before. Equity in the 2025 report amounted to DKK 136,144,994.